Boyu

Boyu Capital is a leading China-focused private equity firm that maintains a significant presence in the healthcare and life sciences sectors. The firm provides growth capital and strategic support to high-growth companies across various stages, from early-stage venture to late-stage private equity and public markets. In the healthcare space, Boyu Capital has built a robust portfolio by investing in industry leaders such as WuXi AppTec, Innovent Biologics, and Ocumension Therapeutics. The firm leverages its deep industry expertise and extensive network to help its portfolio companies scale operations and navigate the complex regulatory landscape in China and globally.